These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 2210153)

  • 1. Heart failure: mechanisms of cardiac and vascular dysfunction and the rationale for pharmacologic intervention.
    Francis GS; Cohn JN
    FASEB J; 1990 Oct; 4(13):3068-75. PubMed ID: 2210153
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Physiologic basis of vasodilator therapy for heart failure.
    Cohn JN
    Am J Med; 1981 Jul; 71(1):135-9. PubMed ID: 7018235
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vasodilators in myocardial infarction: rationale and current status.
    Amsterdam EA; Awan NA; DeMaria AN; Mason DT
    Drugs; 1978 Dec; 16(6):506-21. PubMed ID: 365511
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cardiocirculatory dynamics in the normal and failing heart.
    Zelis R; Flaim SF; Liedtke AJ; Nellis SH
    Annu Rev Physiol; 1981; 43():455-76. PubMed ID: 6452090
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical aspects of left ventricular diastolic function assessed by Doppler echocardiography following acute myocardial infarction.
    Poulsen SH
    Dan Med Bull; 2001 Nov; 48(4):199-210. PubMed ID: 11767125
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Unloading the heart in congestive heart failure.
    Cohn JN
    Am J Med; 1984 Aug; 77(2A):67-70. PubMed ID: 6383033
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Acute and chronic cardiac decompensation: is vasodilator therapy useful?].
    Malacco E; Limonta A; Milanesi A; Micossi P
    Minerva Med; 1982 Jan; 73(1-2):25-32. PubMed ID: 7058000
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pathophysiology and treatment of congestive heart failure.
    Just H; Drexler H; Hasenfuss G
    Cardiology; 1994; 84 Suppl 2():99-107. PubMed ID: 7954551
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combination of positive inotropic and vasodilating substances in congestive heart failure.
    Cantelli I; Bracchetti D
    Cardiovasc Drugs Ther; 1988 May; 2(1):83-91. PubMed ID: 3154699
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regulation of coronary blood flow during exercise.
    Duncker DJ; Bache RJ
    Physiol Rev; 2008 Jul; 88(3):1009-86. PubMed ID: 18626066
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Hemodynamic guidelines in the treatment of acute myocardial infarction by means of vasodilators].
    Zilcher H
    Acta Med Austriaca Suppl; 1979; 15():1-34. PubMed ID: 161946
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Congestive heart failure: what should be the initial therapy and why?
    Chatterjee K
    Am J Cardiovasc Drugs; 2002; 2(1):1-6. PubMed ID: 14727993
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The treatment targets in acute decompensated heart failure.
    Fonarow GC
    Rev Cardiovasc Med; 2001; 2 Suppl 2():S7-S12. PubMed ID: 12439356
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Experts consensus on the management of the right heart function in critically ill patients].
    Wang XT; Liu DW; Zhang HM; Long Y; Guan XD; Qiu HB; Yu KJ; Yan J; Zhao H; Tang YQ; Ding X; Ma XC; Du W; Kang Y; Tang B; Ai YH; He HW; Chen DC; Chen H; Chai WZ; Zhou X; Cui N; Wang H; Rui X; Hu ZJ; Li JG; Xu Y; Yang Y; Ouyan B; Lin HY; Li YM; Wan XY; Yang RL; Qin YZ; Chao YG; Xie ZY; Sun RH; He ZY; Wang DF; Huang QQ; Jiang DP; Cao XY; Yu RG; Wang X; Chen XK; Wu JF; Zhang LN; Yin MG; Liu LX; Li SW; Chen ZJ; Luo Z;
    Zhonghua Nei Ke Za Zhi; 2017 Dec; 56(12):962-973. PubMed ID: 29202543
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vasodilator therapy for heart failure. Concepts, applications, and challenges.
    Rubin SA; Swan HJ
    JAMA; 1981 Feb; 245(7):761-3. PubMed ID: 7463665
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessing the treatment of congestive heart failure: diuretics, vasodilators, and angiotensin-converting enzyme inhibitors.
    Chow MS
    Pharmacotherapy; 1993; 13(5 Pt 2):82S-87S. PubMed ID: 8233997
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Future directions in vasodilator therapy for heart failure.
    Cohn JN
    Am Heart J; 1991 Mar; 121(3 Pt 1):969-74. PubMed ID: 2000775
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Abnormalities of diastolic function as a potential cause of exercise intolerance in chronic heart failure.
    Packer M
    Circulation; 1990 Feb; 81(2 Suppl):III78-86. PubMed ID: 1967559
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Congestive heart failure--pathophysiology and medical treatment.
    Remme WJ
    J Cardiovasc Pharmacol; 1986; 8 Suppl 1():S36-52. PubMed ID: 2422492
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Isosorbide Dinitrate, With or Without Hydralazine, Does Not Reduce Wave Reflections, Left Ventricular Hypertrophy, or Myocardial Fibrosis in Patients With Heart Failure With Preserved Ejection Fraction.
    Zamani P; Akers S; Soto-Calderon H; Beraun M; Koppula MR; Varakantam S; Rawat D; Shiva-Kumar P; Haines PG; Chittams J; Townsend RR; Witschey WR; Segers P; Chirinos JA
    J Am Heart Assoc; 2017 Feb; 6(2):. PubMed ID: 28219917
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.